Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dina Essam Abo-elnour"'
Autor:
Hazem Mohamed Salamah, Ahmed Marey, Esraa Elsayed, Mohammed Tarek Hasan, Abdelrahman Mahmoud, Khaled Alsayed Abualkhair, Dina Essam Abo-elnour, Ibrahim Abdelmonaem Abdelhaleem, Mohamed Abd-Elgawad
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Polyethylene glycol loxenatide (PEX168) is a novel glucagon-like peptide-1 receptor agonist with a longer half-life developed by modifying the chemical structure of exenatide. This study aims to assess the efficacy and safety of PEX168 and d
Externí odkaz:
https://doaj.org/article/4335a15366b24cd994a93329b0e712fe
Autor:
Alaa Mohamed Zaki, Dina Essam Abo-Elnour, Yomna Emad Abdalla, Rehab Yosri Hassan, Moaz Khaled Salama, Toka Elboraay, Ibrahim Abdelmonaem Abdelhaleem
Publikováno v:
Diabetesmetabolic syndrome. 16(11)
Licogliflozin is a dual SGLT1/2 inhibitor acting on the intestine and kidney by reducing glycemic and calorie content. We aimed to determine the efficacy and safety of licogliflozin on Anthropometric measurements and cardiometabolic parameters in obe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e06b59301b0ef870614e1cdaf42d8b6
https://pubmed.ncbi.nlm.nih.gov/36335885
https://pubmed.ncbi.nlm.nih.gov/36335885